Characteristics | Values |
---|---|
Patients numbers | 147 |
Cytokines–biopsy time intervala (months) | 27.93 (6.17–63.37) |
Mean age (yr) | 35 (29–45) |
Male, n (%) | 71 (48.3) |
Systolic BP (mmHg) | 120 (110–130) |
Diastolic BP (mmHg) | 75 (70–80) |
Mean arterial pressure (mmHg) | 90 (83–97) |
Urinary red blood cell (/μL) | 29 (7–79) |
Urinary protein to serum creatinine ratio (mg/g Cr) | 595 (244–1305) |
24-h urine protein excretion (g/24 h) | 0.82 (0.38–1.55) |
< 0.3 | 27 (18.4%) |
0.3–0.99 | 59 (40.1%) |
1.0–2.99 | 46 (31.3%) |
≥ 3 | 15 (10.2%) |
Serum creatinine (mg/dL) | 1.07 (0.84–1.39) |
Serum IgA (g/L) | 2.22 (1.82–3.22) |
Cystatin C (mg/dL) | 1.06 (0.93–1.57) |
eGFR (mL/min•1.73m2)b | 79.29 (60.00–104.29) |
CKD Stagesc, n (%) | |
1 | 57 (38.8) |
2 | 49 (33.3) |
3a | 22 (15.0) |
3b | 8 (5.4) |
4 | 5 (3.4) |
5 | 6 (4.1) |
Oxford classificationd, n (%) | |
M0/ M1 | 16(10.9), 131(89.1) |
E0/E1 | 113(76.9), 34(23.1) |
S0/S1 | 24(16.3), 123(83.7) |
T0/T1/T2 | 45(30.6), 65(44.2), 37(44.2) |
C0/C1/C2 | 66(44.9), 66(44.9), 15(10.2) |
Medical treatments, n (%) | |
Untreated | 35 (23.8) |
Corticosteroids | 71 (48.3) |
Immunosuppressants | 76 (51.7) |
ACE-Is/ARBs | 99 (67.3) |